Logo
D

Diamond Capital Management

13 employees

Diamond Capital Management is dedicated to offering clients well managed alternative investment products that offer consistent returns.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology2
Medical Device2
Health Care2
Pharmaceutical1
Therapeutics1
Neuroscience1
Medical1
Life Science1

Funding rounds participated in

$33M sweet spot round size

Most of their 3 investments are in rounds between $12M and $33M

Investor type

Private Equity Firm

Basic info

Industry

investment management

Sectors

Finance
Managed Futures
Commodity Trading Advisor (CTA)
Trading

Date founded

2002

Investments made

C

CytoPherx, Inc. raised $12M on June 17, 2010

Investors: Diamond Capital Management

T

TransMolecular raised $33M on March 1, 2004

Investors: TVM Life Science Management Inc, Greer Capital Advisors, Oakwood Medical Center, Tullis Health Investors, Pacific Horizon Ventures, MSD Partners, L.P., Easton Capital Investment Group and Diamond Capital Management

N

NeurogesX, Inc. raised $35M on February 24, 2004

Investors: Montreux Equity Partners, TIAA, ARCH Venture Partners, Alta Partners, University of North Carolina at Chapel Hill and Diamond Capital Management

FAQ